Journal of Neuroinfectious Diseases
Open Access

Neurocysticercosis (NCC) is a parasitic infection of the central nervous system caused by the larval stage of Taenia solium, the pork tapeworm. It is a major cause of neurological morbidity and mortality in many developing countries, particularly in regions with poor sanitation and limited access to healthcare. NCC poses a significant public health challenge, contributing to seizures, headaches, and other neurological symptoms. This article explores the epidemiology, clinical presentation, diagnosis, treatment, and prevention strategies for neurocysticercosis.Neurocysticercosis is prevalent in regions where pigs are raised in close contact with humans, particularly in developing countries in Latin America, sub-Saharan Africa, and parts of Asia. The World Health Organization (WHO) estimates that NCC affects over 2 million people globally, with varying prevalence rates depending on geographic and socio-economic factors. Poor sanitation, inadequate hygiene practices, and lack of access to healthcare are significant risk factors contributing to the spread of this infection.Transmission occurs through the fecal-oral route. Humans become infected by ingesting eggs of T. solium, often through contaminated food or water, or through close contact with infected individuals. The larvae hatch in the intestines, penetrate the intestinal wall, and disseminate to various tissues, including the brain, where they can develop into cysts.Once the larvae invade the CNS, they can form cysticerci, which are fluid-filled sacs containing the larval form of the parasite. These cysts can be located in various brain regions, including the cerebral cortex, ventricles, and the spinal cord. The presence of cysticerci in the brain can elicit an inflammatory response, leading to a range of neurological symptoms.The immune response to the larvae varies depending on their viability. Viable cysts may remain asymptomatic for years, but as they degenerate, they can provoke a more robust inflammatory response, resulting in symptoms such as seizures, headaches, and hydrocephalus [1].

Methodology

The clinical manifestations of neurocysticercosis are diverse and depend on the location, number, and viability of cysts. The most common symptom is seizures, which can range from focal to generalized tonic-clonic seizures. Other neurological symptoms may include:

Headaches: Often presenting as chronic or recurrent, headaches can be a direct result of the presence of cysts or increased intracranial pressure [2].

Cognitive impairment: Patients may experience memory loss, confusion, or changes in personality due to the effects of cysts on brain function.

Focal neurological deficits: Depending on the cyst’s location, patients may exhibit weakness, sensory deficits, or speech difficulties [3].

Hydrocephalus: Cysts located in the ventricular system can obstruct cerebrospinal fluid flow, leading to increased intracranial pressure and potentially life-threatening complications [4].

Neuroimaging: Magnetic resonance imaging (MRI) and computed tomography (CT) scans are crucial for identifying cysts in the brain [5]. MRI is more sensitive than CT for detecting small or calcified cysts.

Serological tests: Blood tests can detect antibodies against T. solium, although their sensitivity and specificity vary. Enzyme-linked immunoelectrotransfer blot (EITB) is a highly sensitive and specific test used for diagnosing NCC [6].

Clinical history: A thorough clinical history, including potential exposure to contaminated food or water and travel to endemic regions, is vital for diagnosis.

Epidemiological studies: Population-based surveys are conducted in endemic regions to assess the prevalence and incidence of NCC [7,8]. These studies often utilize structured questionnaires to gather data on risk factors such as sanitation practices, pig husbandry, and socio-economic status.

Clinical evaluation: Patients presenting with neurological symptoms undergo a thorough clinical assessment, including detailed medical history and neurological examination. This helps identify potential cases of NCC [9].

Diagnostic techniques: Neuroimaging plays a crucial role in diagnosing NCC. Patients typically receive magnetic resonance imaging (MRI) or computed tomography (CT) scans to visualize cysts in the central nervous system. Serological tests, such as enzyme-linked immunoelectrotransfer blot (EITB), are employed to detect antibodies against T. solium, providing supportive evidence for diagnosis.

Treatment protocols: For confirmed cases, treatment regimens involve administering antiparasitic medications (e.g., albendazole or praziquantel) alongside corticosteroids to manage inflammation. Clinical outcomes are monitored through follow-up visits and repeat imaging as necessary [10].

Conclusion

Neurocysticercosis remains a significant public health challenge, particularly in endemic regions. Understanding its epidemiology, clinical presentation, and treatment options is crucial for effective management and prevention. Enhanced public health initiatives aimed at improving sanitation, promoting education, and developing effective vaccines will be pivotal in combating this debilitating disease. Continued research into the pathophysiology and treatment of NCC is essential to reduce its burden and improve outcomes for affected individuals. Preventive measures, including enhancing sanitation, promoting hygiene education, and implementing effective food safety practices, are essential to reduce the incidence of NCC. Future research is crucial to develop vaccines and improve treatment protocols, addressing the challenges posed by this infection.In summary, a comprehensive approach that includes better diagnostics, effective treatment, and robust prevention strategies is essential for combating neurocysticercosis and mitigating its impact on global health. Collaboration among healthcare providers, researchers, and communities will be key to achieving these goals and improving outcomes for those affected by NCC.

1. Amudhan S, Gururaj G, Satishchandra P (2015) Epilepsy in India I: Epidemiology and public health. Ann Indian Acad Neurol 18: 263-277.

Indexed at, Google Scholar, Crossref

2. Nash TE, Garcia HH (2011) Diagnosis and Treatment of Neurocysticercosis. Nature reviews Neurology 7: 584-594.

Indexed at, Google Scholar, Crossref

3. Garcia HH, Nash TE, Del Brutto OH (2014) Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13: 1202-1215.

Indexed at, Google Scholar, Crossref

4. Kimura-Hayama ET, Higuera JA, Corona-Cedillo R, Chávez-Macías L, Perochena A, et al. (2010) Neurocysticercosis: radiologic-pathologic correlation. Radiographics 30: 1705-1719.

Indexed at, Crossref

5. Lerner A, Shiroishi MS, Zee CS (2012) Imaging of neurocysticercosis. Neuroimaging Clin N Am 22: 659.

Indexed at, Google Scholar, Crossref

6. Castillo M (2004) Imaging of neurocysticercosis. Semin Roentgenol 39: 465-473.

Indexed at, Google Scholar, Crossref

7. Hingwala, Divyata (2011) Applications of 3D CISS Sequence for Problem Solving in Neuroimaging. The Indian Journal of Radiology Imaging 21: 90-97.

Indexed at, Google Scholar, Crossref

8. Govindappa SS, Narayanan JP, Krishnamurthy VM (2000) Improved detection of intraventricular cysticercal cysts with the use of three-dimensional constructive interference in steady state MR sequence. AJNR Am J Neuroradiol 21: 679-684.

Indexed at, Google Scholar

9. Zhao JL, Lerner A, Sh Z, Gao X J, Zee CS (2015) Imaging spectrum of neurocysticercosis. Radiology of Infectious Diseases, 1: 94-102.

Indexed at, Google Scholar, Crossref

10. Braga F, Rocha A J, Gomes H R, Hernandez Filho G, Fonseca RB (2004) Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O2 in the evaluation of neurocysticercosis. AJNR Am J Neuroradiol 25: 295-297.

Indexed at, Google Scholar